Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Francisco J. Hernandez-Illizaliturri"'
Autor:
Dorothy A. Shead, Ruby F. Meredith, Keith Stockerl-Goldstein, Amrita Krishnan, Benjamin Djulbegovic, Kenneth C. Anderson, Seema Singhal, Joachim Yahalom, Adam D. Cohen, Jeffrey Schriber, Michael Liedtke, William I. Bensinger, Carol Ann Huff, Furhan Yunus, Francisco J. Hernandez-Illizaliturri, Rashmi Kumar, Adetola A. Kassim, J. Sybil Biermann, Cristina Gasparetto, Donna M. Weber, Noopur Raje, Steven M. Devine, Edward A. Faber, George Somlo, Steven P. Treon, Melissa Alsina
Publikováno v:
Journal of the National Comprehensive Cancer Network. 11:11-17
These NCCN Guidelines Insights highlight the important updates/changes specific to the management of relapsed or progressive disease in the 2013 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::128cd17c70113ba33d6ea1035b12ef36
https://doi.org/10.6004/jnccn.2013.0004
https://doi.org/10.6004/jnccn.2013.0004
Autor:
Nancy L. Bartlett, Jennie M. Lorenz, Stephen J. Proctor, Bruce D. Cheson, Francine M. Foss, Andres Forero-Torres, André Bosly, John P. Leonard, Elliott Epner, Jeremy Barton, Ajay K. Gopal, Harve Tilly, Pauline Brice, Mats Jerkeman, Joseph D. Rosenblatt, Francisco J. Hernandez-Illizaliturri, Corinne Haioun, Steven H. Bernstein
Publikováno v:
Blood. 104:2637-2637
SGN-30 is a chimeric mAb which recognizes the CD30 antigen found on tumor cells from patients (pts) with Hodgkin’s disease (HD) and anaplastic large cell lymphoma (ALCL). In preclinical experiments, SGN-30 was shown to have antitumor activity in bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93ca09dbc6cbaad92b1131374c6002ac
https://doi.org/10.1182/blood.v104.11.2637.2637
https://doi.org/10.1182/blood.v104.11.2637.2637